Physical Activity, Blood Lipids, and Lipoproteins

American Journal of Lifestyle Medicine

Volumn 3, Issue 4, 2009, Pages 279-283

  Mestek, Michael L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

apolipoproteins; cardiovascular; dyslipidemia; exercise; prevention

Indexed keywords

EID: 84990334214     PISSN: 15598276     EISSN: None     Source Type: Journal    
DOI: 10.1177/1559827609334885     Document Type: Article

References (54)

1. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004; 44: 720-732.
2. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation. 2004; 109: 11115-11119.
3. Ghandehari H., Kamal-Bahl S., Wong ND Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Am Heart J. 2008; 156: 112-119.
4. Pletcher MJ, Lazar L., Bibbins-Domingo K., et al. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med. 2009; 150: 243-254.
5. Brunzell JD, Davidson M., Furberg CD, et al. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care. 2008; 31: 811-822.
6. Lowensteyn I., Coupal L., Zowall H., Grover SA The cost-effectiveness of exercise training for the primary and secondary prevention of cardiovascular disease. J Cardiopulm Rehabil. 2000; 20: 147-155.
7. Tambalis KD, Panagiotakos DB, Kavouras SA, Sidossis LS Responses of blood lipids to aerobic, resistance, and combined aerobic with resistance exercise training: a systematic review of current evidence. Angiology. Epub ahead of print. October 30, 2008.
8. Castelli WP Lipids, risk factors and ischaemic heart disease. Atherosclerosis. 1996; 124(suppl):51-59.
9. Durstine JL, Grandjean PW, Davis PG, Ferguson MA, Alderson NL, DuBose KD Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis. Sports Med. 2001; 31: 1033-1062.
10. Kokkinos PF, Holland JC, Narayan P., Colleran JA, Dotson CO, Papademetriou V. Miles run per week and high-density lipoprotein cholesterol levels in healthy, middle-aged men: a dose-response relationship. Arch Intern Med. 1995; 155: 415-420.
11. Kiens B., Lithell H., Mikines KJ, Richter EA Effects of insulin and exercise on muscle lipoprotein lipase activity in man and its relation to insulin action. J Clin Invest. 1989; 84: 1124-1129.
12. Lowering blood cholesterol to prevent heart disease. NIH Consensus Development Conference Statement. Arteriosclerosis. 1985; 5: 404-412.
13. Kelley GA, Kelley KS Aerobic exercise and lipids and lipoproteins in men: a meta-analysis of randomized controlled trials. J Mens Health Gend. 2006;3: 61-70.
14. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993; 269: 3015-3023.
15. Steinberg D., Glass CK, Witztum JL Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation. 2008; 118: 672-677.
16. Das DK Cardioprotection with high-density lipoproteins: fact or fiction? Circ Res. 2003; 92: 258-260.
17. Durstine JL, Grandjean PW, Cox CA, Thompson PD Lipids, lipoproteins, and exercise. J Cardiopulm Rehabil. 2002; 22: 385-398.
18. Leon AS, Sanchez OA Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc. 2001; 33: 5502-5515.
19. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989; 79: 8-15.
20. Thompson PD, Cullinane EM, Sady SP, et al. Modest changes in high-density lipoprotein concentration and metabolism with prolonged exercise training. Circulation. 1988; 78: 25-34.
21. Wood PD, Stefanick ML, Williams PT, Haskell WL The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med. 1991; 325: 461-466.
22. Leon AS, Rice T., Mandel S., et al. Blood lipid response to 20 weeks of supervised exercise in a large biracial population: the HERITAGE Family Study. Metabolism. 2000; 49: 513-520.
23. Thompson PD, Rader DJ Does exercise increase HDL cholesterol in those who need it the most? Arterioscler Thromb Vasc Biol. 2001; 21: 1097-1098.
24. Sarwar N., Danesh J., Eiriksdottir G., et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2007; 115: 450-458.
25. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000; 86: 943-949.
26. Jeppesen J., Hein HO, Suadicani P., Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 1998; 97: 1029-1036.
27. Williams PT Relationships of heart disease risk factors to exercise quantity and intensity. Arch Intern Med. 1998; 158: 237-245.
28. Weintraub MS, Rosen Y., Otto R., Eisenberg S., Breslow JL Physical exercise conditioning in the absence of weight loss reduces fasting and postprandial triglyceride-rich lipoprotein levels. Circulation. 1989; 79: 1007-1014.
29. Carmena R., Duriez P., Fruchart JC Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004; 109: I112-I117.
30. Sulkes D., Brown BG, Krauss RM, Segrest JP, Sniderman AD, Roberts WC The editor's roundtable: expanded versus standard lipid panels in assessing and managing cardiovascular risk. Am J Cardiol. 2008; 101: 828-842.
31. Chapman MJ, Guerin M., Bruckert E. Atherogenic, dense low-density lipoproteins: Pathophysiology and new therapeutic approaches. Eur Heart J. 1998; 19(suppl A):124-130.
32. Cromwell WC, Otvos JD Low-density lipoprotein particle number and risk for cardiovascular disease. Curr Atheroscler Rep. 2004; 6: 381-387.
33. O'Donovan G., McEneny J., Kearney EM, et al. LDL particle size in habitual exercisers, lean sedentary men and abdominally obese sedentary men. Int J Sports Med. 2007; 28: 644-649.
34. Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002; 347: 1483-1492.
35. El Harchaoui K., Arsenault BJ, Franssen R., et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med. 2009; 150: 84-93.
36. Halverstadt A., Phares DA, Wilund KR, Goldberg AP, Hagberg JM Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Metabolism. 2007; 56: 444-450.
37. Slentz CA, Houmard JA, Johnson JL, et al. Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol. 2007; 103: 432-442.
38. Ginsberg HN Lipoprotein physiology. Endocrinol Metab Clin North Am. 1998; 27: 503-519.
39. Barter PJ, Rye KA The rationale for using apoA-I as a clinical marker of cardiovascular risk. J Intern Med. 2006; 259: 447-454.
40. Contois JH, McConnell JP, Sethi AA, et al. Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clin Chem. 2009; 55: 407-419.
41. Ring-Dimitriou S., von Duvillard SP, Paulweber B., et al. Nine months aerobic fitness induced changes on blood lipids and lipoproteins in untrained subjects versus controls. Eur J Appl Physiol. 2007; 99: 291-299.
42. Angelopoulos TJ, Sivo SA, Kyriazis GA, et al. Do age and baseline LDL cholesterol levels determine the effect of regular exercise on plasma lipoprotein cholesterol and apolipoprotein B levels? Eur J Appl Physiol. 2007; 101: 621-628.
43. Joy T., Hegele RA Is raising HDL a futile strategy for atheroprotection? Nat Rev Drug Discov. 2008; 7: 143-155.
44. Benderly M., Boyko V., Goldbourt U. Apolipoproteins and long-term prognosis in coronary heart disease patients. Am Heart J. 2009; 157: 103-110.
45. Mora S., Cook N., Buring JE, Ridker PM, Lee IM Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation. 2007; 116: 2110-2118.
46. Thompson PD, Yurgalevitch SM, Flynn MM, et al. Effect of prolonged exercise training without weight loss on high-density lipoprotein metabolism in overweight men. Metabolism. 1997; 46: 217-223.
47. Seip RL, Moulin P., Cocke T., et al. Exercise training decreases plasma cholesteryl ester transfer protein. Arterioscler Thromb. 1993; 13: 1359-1367.
48. Israel RG, Sullivan MJ, Marks RH, Cayton RS, Chenier TC Relationship between cardiorespiratory fitness and lipoprotein(a) in men and women. Med Sci Sports Exerc. 1994; 26: 425-431.
49. Nordestgaard BG, Benn M., Schnohr P., Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007; 298: 299-308.
50. Petitt DS, Cureton KJ Effects of prior exercise on postprandial lipemia: a quantitative review. Metabolism. 2003; 52: 418-424.
51. Gill JM, Hardman AE Exercise and postprandial lipid metabolism: an update on potential mechanisms and interactions with high-carbohydrate diets (review). J Nutr Biochem. 2003; 14: 122-132.
52. Gill JM, Herd SL, Hardman AE Moderate exercise and post-prandial metabolism: issues of dose-response. J Sports Sci. 2002; 20: 961-967.
53. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007; 39: 1423-1434.
54. Herd SL, Lawrence JE, Malkova D., Murphy MH, Mastana S., Hardman AE Postprandial lipemia in young men and women of contrasting training status. J Appl Physiol. 2000; 89: 2049-2056.